275 related articles for article (PubMed ID: 17931155)
1. Immunostimulatory DNA as a vaccine adjuvant.
Higgins D; Marshall JD; Traquina P; Van Nest G; Livingston BD
Expert Rev Vaccines; 2007 Oct; 6(5):747-59. PubMed ID: 17931155
[TBL] [Abstract][Full Text] [Related]
2. Immune mechanisms and therapeutic potential of CpG oligodeoxynucleotides.
Wilson HL; Dar A; Napper SK; Marianela Lopez A; Babiuk LA; Mutwiri GK
Int Rev Immunol; 2006; 25(3-4):183-213. PubMed ID: 16818371
[TBL] [Abstract][Full Text] [Related]
3. Presence of CpG DNA and the local cytokine milieu determine the efficacy of suppressive DNA vaccination in experimental autoimmune encephalomyelitis.
Lobell A; Weissert R; Eltayeb S; Svanholm C; Olsson T; Wigzell H
J Immunol; 1999 Nov; 163(9):4754-62. PubMed ID: 10528174
[TBL] [Abstract][Full Text] [Related]
4. Recent advances in the development of immunostimulatory oligonucleotides.
Uhlmann E; Vollmer J
Curr Opin Drug Discov Devel; 2003 Mar; 6(2):204-17. PubMed ID: 12669456
[TBL] [Abstract][Full Text] [Related]
5. Adjuvant properties of CpG oligonucleotides in primates.
Verthelyi D
Methods Mol Med; 2006; 127():139-58. PubMed ID: 16988453
[TBL] [Abstract][Full Text] [Related]
6. Toll-like receptors involved in the response to microbial pathogens: development of agonists for toll-like receptor 9.
Schetter C; Vollmer J
Curr Opin Drug Discov Devel; 2004 Mar; 7(2):204-10. PubMed ID: 15603254
[TBL] [Abstract][Full Text] [Related]
7. Enhancing vaccines with immune stimulatory CpG DNA.
Krieg AM; Davis HL
Curr Opin Mol Ther; 2001 Feb; 3(1):15-24. PubMed ID: 11249727
[TBL] [Abstract][Full Text] [Related]
8. CpG motifs for optimization of DNA vaccines.
Davis HL
Dev Biol (Basel); 2000; 104():165-9. PubMed ID: 11713816
[TBL] [Abstract][Full Text] [Related]
9. The role of CpG dinucleotides in DNA vaccines.
Krieg AM; Yi AK; Schorr J; Davis HL
Trends Microbiol; 1998 Jan; 6(1):23-7. PubMed ID: 9481820
[TBL] [Abstract][Full Text] [Related]
10. Adjuvant activity of CpG oligodeoxynucleotides.
Klinman DM
Int Rev Immunol; 2006; 25(3-4):135-54. PubMed ID: 16818369
[TBL] [Abstract][Full Text] [Related]
11. Discovery of immunostimulatory CpG-DNA and its application to tuberculosis vaccine development.
Yamamoto S; Yamamoto T; Nojima Y; Umemori K; Phalen S; McMurray DN; Kuramoto E; Iho S; Takauji R; Sato Y; Yamada T; Ohara N; Matsumoto S; Goto Y; Matsuo K; Tokunaga T
Jpn J Infect Dis; 2002 Apr; 55(2):37-44. PubMed ID: 12082305
[TBL] [Abstract][Full Text] [Related]
12. TLR9 agonists as adjuvants for prophylactic and therapeutic vaccines.
Daubenberger CA
Curr Opin Mol Ther; 2007 Feb; 9(1):45-52. PubMed ID: 17330401
[TBL] [Abstract][Full Text] [Related]
13. In vitro assay of immunostimulatory activities of plasmid vectors.
Jiang W; Reich CF; Pisetsky DS
Methods Mol Med; 2006; 127():55-70. PubMed ID: 16988446
[TBL] [Abstract][Full Text] [Related]
14. DNA vaccines in sheep: CTLA-4 mediated targeting and CpG motifs enhance immunogenicity in a DNA prime/protein boost strategy.
Kennedy NJ; Spithill TW; Tennent J; Wood PR; Piedrafita D
Vaccine; 2006 Feb; 24(7):970-9. PubMed ID: 16242220
[TBL] [Abstract][Full Text] [Related]
15. Strategies for enhancing the immunostimulatory effects of CpG oligodeoxynucleotides.
Mutwiri GK; Nichani AK; Babiuk S; Babiuk LA
J Control Release; 2004 May; 97(1):1-17. PubMed ID: 15147800
[TBL] [Abstract][Full Text] [Related]
16. Synthetic methylated CpG ODNs are potent in vivo adjuvants when delivered in liposomal nanoparticles.
Chikh G; de Jong SD; Sekirov L; Raney SG; Kazem M; Wilson KD; Cullis PR; Dutz JP; Tam YK
Int Immunol; 2009 Jul; 21(7):757-67. PubMed ID: 19502586
[TBL] [Abstract][Full Text] [Related]
17. CpG motifs to modulate innate and adaptive immune responses.
Vollmer J
Int Rev Immunol; 2006; 25(3-4):125-34. PubMed ID: 16818368
[TBL] [Abstract][Full Text] [Related]
18. Recent advances in immunostimulatory CpG oligonucleotides.
Rothenfusser S; Tuma E; Wagner M; Endres S; Hartmann G
Curr Opin Mol Ther; 2003 Apr; 5(2):98-106. PubMed ID: 12772497
[TBL] [Abstract][Full Text] [Related]
19. Decreased suppression of immune stimulatory CpG motifs in plant DNA.
Wang Y; Zhou J; Liu B
Immunol Lett; 2007 Dec; 114(2):73-80. PubMed ID: 17889375
[TBL] [Abstract][Full Text] [Related]
20. Enhancing immunogenicity by CpG DNA.
Jiang W; Pisetsky DS
Curr Opin Mol Ther; 2003 Apr; 5(2):180-5. PubMed ID: 12772509
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
